Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCORI Chairman Washington To Step Down At The End Of 2013

This article was originally published in The Pink Sheet Daily

Executive Summary

Bringing the notion of patient-centered research to the wider health care community is an accomplishment highlighted by Eugene Washington in an interview.

You may also be interested in...



Incoming Chairman Norquist Plans For PCORI To Continue Beyond 2019

The health care reform law that created the Patient-Centered Outcomes Research Institute sunsets funding in 2019, but incoming Chairman Grayson Norquist is planning to lead the organization with the assumption that PCORI will continue beyond then.

PCORI Names New Chairman: Grayson Norquist Could Bring Greater Focus To Research Community Outreach

Founding Patient-Centered Outcomes Research Institute board member Grayson Norquist, who will succeed Eugene Washington as chairman Sept. 23, has been outspoken on the need for more and better outreach to the research community.

FDA Hunting For Ways To Expand Patient Role In Drug Development

Agency’s Patient Network Annual Meeting will help explain the drug development process along with agency and patient roles as part of ongoing effort to increase patient involvement.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS076091

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel